Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.
Grosso F, Mannucci M, Ugo F, Ferro P, Cassinari M, Vigani A, De Angelis AM, Delfanti S, Lia M, Guaschino R, Barbero S, Roncella S, Giannoni U, Bertolotti M, Pistillo MP, Fontana V. Grosso F, et al. Among authors: ugo f. Diagnostics (Basel). 2021 Oct 29;11(11):2015. doi: 10.3390/diagnostics11112015. Diagnostics (Basel). 2021. PMID: 34829362 Free PMC article.
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
Canova S, Ceresoli GL, Grosso F, Zucali PA, Gelsomino F, Pasello G, Mencoboni M, Rulli E, Galli F, De Simone I, Carlucci L, De Angelis A, Belletti M, Bonomi M, D'Aveni A, Perrino M, Bono F, Cortinovis DL; DIADEM groupD. Canova S, et al. ESMO Open. 2022 Dec;7(6):100644. doi: 10.1016/j.esmoop.2022.100644. Epub 2022 Dec 1. ESMO Open. 2022. PMID: 36463732 Free PMC article. Clinical Trial.
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Piccirillo MC, et al. Among authors: ugo f. J Thorac Oncol. 2023 Jun;18(6):813-819. doi: 10.1016/j.jtho.2023.02.003. Epub 2023 Feb 24. J Thorac Oncol. 2023. PMID: 36841541 Free article. Clinical Trial.
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Piccirillo MC, et al. Among authors: ugo f. J Thorac Oncol. 2024 Nov;19(11):1578-1579. doi: 10.1016/j.jtho.2024.08.017. Epub 2024 Aug 24. J Thorac Oncol. 2024. PMID: 39186030 No abstract available.
How primary care research can be improved in clinical practice? An Italian case study.
Roveta A, Pacileo G, Cappelletti M, Alesso D, Bonissone A, Fossati L, Giaccari MC, Maccapani F, Milano C, Parodi N, Torregiani F, Ugo F, Massarino C, Castello LM, Maconi AG. Roveta A, et al. Among authors: ugo f. Minerva Med. 2024 Apr;115(2):162-170. doi: 10.23736/S0026-4806.24.09044-X. Epub 2024 Apr 4. Minerva Med. 2024. PMID: 38576354 Free article.
Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric Setting.
Bottino P, Massarino C, Leli C, Scomparin E, Bara C, Gotta F, Cornaglia E, Felici E, Gentile M, Ranzan S, Francese A, Ugo F, Penpa S, Roveta A, Maconi A, Rocchetti A. Bottino P, et al. Among authors: ugo f. Viruses. 2024 Oct 20;16(10):1638. doi: 10.3390/v16101638. Viruses. 2024. PMID: 39459970 Free PMC article.
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics.
Colaiori I, Biondi-Zoccai G, Spadafora L, Bernardi M, Aloia A, Ancona M, Aprigliano G, Barbato E, Baldi C, Briguori C, Buja P, Cadeddu M, Casu G, De Caterina A, DE Felice F, DE Simone C, Donazzan L, Ferranti F, Franco N, Gaspardone A, Hiso E, Leoncini M, Leone A, Lucreziotti S, Mancone M, Marinucci L, Maioli M, Montorfano M, Musarò S, Niglio T, Picchi A, Poli A, Preti G, Ribichini FL, Rolandi A, Romagnoli E, Sangiorgi GM, Serino F, Soldà P, Tiberti G, Tomai F, Tomassini F, Ugo F, Esposito G, Saia F, Versaci F. Colaiori I, et al. Among authors: ugo f. Panminerva Med. 2024 Dec 20. doi: 10.23736/S0031-0808.24.05277-7. Online ahead of print. Panminerva Med. 2024. PMID: 39705020
Long-Term Prognosis of Coronary Aneurysms: Insights of CAAR, an International Registry.
Sánchez-Sánchez I, Cerrato E, Bollati M, Espejo-Paeres C, Nombela-Franco L, Alfonso-Rodríguez E, Camacho-Freire SJ, Villablanca PA, Amat-Santos IJ, De la Torre Hernández JM, Pascual I, Liebetrau C, Camacho B, Pavani M, Albistur J, Latini RA, Varbella F, Jiménez Díaz VA, Piraino D, Mancone M, Alfonso F, Linares JA, Rodríguez-Olivares R, Jiménez-Mazuecos JM, Palazuelos Molinero J, Sánchez-Grande Flecha A, Gomez-Hospital JA, Ielasi A, Lozano Í, Omedè P, Feltes G, Ugo F, Medda M, Ramakrishna H, Kala P, Bautista D, Alkhouli M, Fernández-Ortiz A, Núñez-Gil IJ; CAAR Investigators. Sánchez-Sánchez I, et al. Among authors: ugo f. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2681-2691. doi: 10.1016/j.jcin.2024.08.034. JACC Cardiovasc Interv. 2024. PMID: 39603781
106 results